A Daily Network publication
Explore the network
Wealth Advisor Daily
The advisor's edition — practice, portfolio, and the book.
Wednesday, October 7, 2026The Morning Brief →Sign in

Who holds CRSPCRISPR THERAPEUTICS AG

13 funds on our shelf carry CRISPR THERAPEUTICS AG — heaviest hand: GNOM at 2.70% of its book.

FundWeightFund assetsShares held
GNOMGlobal X Genomics & Biotechnology ETFINDEX2.70%$85M50,453
IDNAiShares Genomics Immunology and Healthcare ETFINDEX1.43%$317M79,111
XBIState Street SPDR S&P Biotech ETFINDEX1.02%$10.3B2,006,430
IBBiShares Biotechnology ETFINDEX0.37%$10.6B679,191
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.36%$112M6,896
VTWVVanguard Russell 2000 Value ETFINDEX0.30%$813M75,907
IWNiShares Russell 2000 Value ETFINDEX0.28%$13.9B759,792
VTWOVanguard Russell 2000 ETFINDEX0.17%$9.9B535,930
RSSLGlobal X Russell 2000 ETFINDEX0.17%$1.5B42,698
ISCViShares Morningstar Small-Cap Value ETFINDEX0.16%$661M20,690
IWMiShares Russell 2000 ETFINDEX0.16%$79.3B2,346,459
PDNInvesco RAFI Developed Markets ex-U.S. Small-Mid ETFINDEX0.11%$349M6,887
XTiShares Exponential Technologies ETFINDEX0.03%$4.1B18,651

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

Every weekday · 6:30 a.m. ET

The Morning Brief

The latest from Wealth Advisor Daily, in your inbox every weekday. Free.